The oil spill in ageing Bruch membrane

British Journal of Ophthalmology

Volumn 95, Issue 12, 2011, Pages 1638-1645

  Curcio, Christine A ^a   Johnson, Mark ^b   Rudolf, Martin ^c   Huang, Jiahn Dar ^d  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Northwestern University   (United States)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B;

AGING; BINDING AFFINITY; BINDING SITE; BIOACCUMULATION; BRUCH MEMBRANE; CELL ULTRASTRUCTURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EYE INJURY; HISTOCHEMISTRY; HUMAN; LIPID STORAGE; LIPOGENESIS; MOLECULAR PATHOLOGY; MOLECULAR WEIGHT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRATEGIC PLANNING; SUBRETINAL NEOVASCULARIZATION;

AGING; APOLIPOPROTEINS B; BRUCH MEMBRANE; FEMALE; HUMANS; LIPOPROTEINS, HDL; MACULAR DEGENERATION; MALE; RISK FACTORS;

EID: 81555204445     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300344     Document Type: Review

References (107)

1. Miller JW. Treatment of age-related macular degeneration: beyond VEG-F. Jpn J Ophthalmol 2010;54:523-8.
2. Pauleikhoff D, Harper CA, Marshall J, et al. Aging changes in Bruch's membrane: a histochemical and morphological study. Ophthalmology 1990;97:171-8. (Pubitemid 20051380)
3. Sheraidah G, Steinmetz R, Maguire J, et al. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology 1993;100:47-51. (Pubitemid 23041129)
4. Holz FG, Sheraidah G, Pauleikhoff D, et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994;112:402-6. (Pubitemid 24085153)
5. Wolter JR, Falls HF. Bilateral confluent drusen. Arch Ophthalmol 1962;68:219-26.
6. Pauleikhoff D, Zuels S, Sheraidah GS, et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 1992;99:1548-53.
7. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 1995;36:1290-7.
8. Starita C, Hussain AA, Marshall J. Decreasing hydraulic conductivity of Bruch's membrane: relevance to photoreceptor survival and lipofuscinoses. Am J Med Genet 1995;57:235-7.
9. Starita C, Hussain AA, Pagliarini S, et al. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp Eye Res 1996;62:565-72.
10. Starita C, Hussain AA, Patmore A, et al. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci 1997;38:762-7. (Pubitemid 27143147)
11. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353-9. (Pubitemid 28124364)
12. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200-6. (Pubitemid 30428336)
13. Zerbib J, Seddon JM, Richard F, et al. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 2009;4:-7341.
14. Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 2010;107:7395-400.
15. Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 2010;107:7401-6.
16. Curcio CA, Johnson M, Huang JD, et al. Aging, age-related macular degeneration, and the Response-to-Retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 2009;28:393-422.
17. Curcio CA, Johnson M, Huang JD, et al. Apolipoprotein B-containing lipoproteins in retinal aging and age-related maculopathy. J Lipid Res 2010;51:451-67.
18. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-61.
19. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832-44. (Pubitemid 350287108)
20. Ruberti JW, Curcio CA, Millican CL, et al. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Invest Ophthalmol Vis Sci 2003;44:1753-9. (Pubitemid 36378607)
21. Huang JD, Presley JB, Chimento MF, et al. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp Eye Res 2007;85:202-18. (Pubitemid 47087796)
22. Curcio CA, Millican CL, Bailey T, et al. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 2001;42:265-74. (Pubitemid 32059440)
23. Haimovici R, Gantz DL, Rumelt S, et al. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing microscopy. Invest Ophthalmol Vis Sci 2001;42:1592-9. (Pubitemid 32520753)
24. Rudolf M, Curcio CA. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J Histochem Cytochem 2009;57:731-9.
25. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988;2:552-77. (Pubitemid 19142671)
26. Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999;117:329-39. (Pubitemid 29133727)
27. Malek G, Li C-M, Guidry C, et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits in eyes with age-related maculopathy. Am J Pathol 2003;162:413-25. (Pubitemid 36267849)
28. Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS One 2010;5:-10329.
29. Rudolf M, Clark ME, Chimento M, et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci 2008;49:1200-9.
30. Li C-M, Clark ME, Chimento MF, et al. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci 2006;47:3119-28. (Pubitemid 351639791)
31. Sarks S, Cherepanoff S, Killingsworth M, et al. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci 2007;48:968-77. (Pubitemid 351261384)
32. Zweifel SA, Spaide RF, Curcio CA, et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010;117:303-12.e.1.
33. Hodge AM, Barnes D, Schacter HM, et al. Effects of Omega-3 Fatty Acids on Eye Health. Rockville, MD: Agency for Healthcare Research and Quality, 2005.
34. Vance DE, Vance JE, eds. Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier, 2002.
35. Li CM, Chung BH, Presley JB, et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci 2005;46:2576-86. (Pubitemid 43119509)
36. Wang L, Li CM, Rudolf M, et al. Lipoprotein particles of intra-ocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci 2009;50:870-7.
37. Shoulders CC, Shelness GS. Current biology of MTP: implications for selective inhibition. Curr Top Med Chem 2005;5:283-300. (Pubitemid 40614129)
38. Chowers I, Banin E, Merin S, et al. Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. Eye (Lond) 2001;15:525-30. (Pubitemid 32755726)
39. Li CM, Presley JB, Zhang X, et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J Lipid Res 2005;46:628-40. (Pubitemid 43073272)
40. Wu T, Fujihara M, Tian J, et al. Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels. J Neurochem 2010;114:1734-44.
41. Bretillon L, Thuret G, Gregoire S, et al. Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid, and the lacrimal gland, and associations with adipose tissue fatty acids in human subjects. Exp Eye Res 2008;87:521-8.
42. Gülcan H, Alvarez R, Maude M, et al. Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid: comparison of macular and peripheral regions. Invest Ophthalmol Vis Sci 1993;34:3187-93. (Pubitemid 23309058)
43. Spaide R, Ho-Spaide W, Browne R, et al. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999;19:141-7. (Pubitemid 30368160)
44. Liu A, Chang J, Lin Y, et al. Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res 2011;51:3217-29.
45. Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008;14:194-8. (Pubitemid 351214555)
46. Ishida BY, Bailey KR, Duncan KG, et al. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 2004;45:263-71. (Pubitemid 38228823)
47. Ishida BY, Duncan KG, Bailey KR, et al. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br J Ophthalmol 2006;90:616-20.
48. Mast N, Reem R, Bederman I, et al. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism to that in the brain. Invest Ophthalmol Vis Sci 2011;52:594-603.
49. Hogan MJ. Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol 1972;76:64-80.
50. Dashti N, McGwin G Jr, Owsley C, et al. Plasma apolipoproteins and risk for age-related maculopathy. Br J Ophthalmol 2006;90:1028-33. (Pubitemid 44140187)
51. Contois JH, McConnell JP, Sethi AA, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2009;55:407-19.
52. Peponis V, Chalkiadakis SE, Bonovas S, et al. The controversy over the association between statins use and progression of age-related macular degeneration: a mini review. Clin Ophthalmol 2010;4:865-9.
53. Loane E, Nolan JM, O'Donovan O, et al. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol 2008;53:68-81.
54. Tserentsoodol N, Sztein J, Campos M, et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis 2006;12:1306-18. (Pubitemid 44688464)
55. Hayes KC, Lindsey S, Stephan ZF, et al. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci 1989;30:225-32. (Pubitemid 19055599)
56. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared to beta -carotene by retinal cells via a scavenger receptor BI-dependent mechanism. J Lipid Res 2008;49:1715-24.
57. Tserentsoodol N, Gordiyenko NV, Pascual I, et al. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis 2006;12:1319-33. (Pubitemid 44688463)
58. Provost A, Vede L, Bigot K, et al. Morphological and electroretinographic phenotype of SRBI knock-out mice after a long term atherogenic diet. Invest Ophthalmol Vis Sci 2009;50:3931-42.
59. Bazan NG, Gordon WC, Rodriguez de Turco EB. Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv Exp Med Biol 1992;318:295-306.
60. Yamada Y, Tian J, Yang Y, et al. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem 2008;105:1187-97. (Pubitemid 351590780)
61. Qtaishat NM, Redmond TM, Pepperberg DR. Acute radiolabeling of retinoids in eye tissues of normal and rp-65-deficient mice. Invest Ophthalmol Vis Sci 2003;44:1435-46. (Pubitemid 36378566)
62. Duncan KG, Hosseini K, Bailey KR, et al. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol 2009;93:1116-20.
63. Ethier CR, Johnson M, Ruberti J. Ocular biomechanics and biotransport. Annu Rev Biomed Eng 2004;6:249-73. (Pubitemid 39209499)
64. Moreira EF, Larrayoz IM, Lee JW, et al. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Invest Ophthalmol Vis Sci 2009;50:523-32.
65. Beattie JR, Pawlak AM, Boulton ME, et al. Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane. FASEB J 2010;24:4816-24.
66. Upston JM, Niu X, Brown AJ, et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002;160:701-10. (Pubitemid 34160348)
67. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degenerationewhat is the cause? Retina 2003;23:595-614.
68. Tamai K, Spaide RF, Ellis EA, et al. Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. Exp Eye Res 2002;74:301-8. (Pubitemid 34948405)
69. Baba T, Bhutto IA, Merges C, et al. A rat model for choroidal neovascularization using subretinal lipid hydroperoxide Injection. Am J Pathol 2010;176:3085-97.
70. Ishibashi T, Patterson R, Ohnishi Y, et al. Formation of drusen in the human eye. Am J Ophthalmol 1986;101:342-53. (Pubitemid 16132662)
71. Strunnikova N, Baffi J, Gonzalez A, et al. Regulated heat shock protein 27 expression in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2001;42:2130-8. (Pubitemid 32726049)
72. Alcazar O, Hawkridge AM, Collier TS, et al. Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics 2009;8:2201-11.
73. Hageman GS, Luthert PJ, Chong NHC, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-32. (Pubitemid 32918285)
74. Sparrow JR. Bisretinoids of RPE Lipofuscin: Trigger for Complement Activation in Age-Related Macular Degeneration. Adv Exp Med Biol 2010;703:63-74.
75. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010;29:95-112.
76. Leitinger N, Watson AD, Hama SY, et al. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol 1999;19:1291-8. (Pubitemid 29227650)
77. Subbanagounder G, Watson AD, Berliner JA. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radic Biol Med 2000;28:1751-61. (Pubitemid 30628662)
78. Miller YI, Chang MK, Binder CJ, et al. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 2003;14:437-45. (Pubitemid 37297298)
79. Van Lenten BJ, Wagner AC, Anantharamaiah GM, et al. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep 2009;11:52-7.
80. Rudolf M, Clark ME, Messinger JD, et al. ApoA-I mimetic peptide reduces lipid deposition in murine Bruch's membrane after intravitreal injection. Invest Ophthalmol Vis Sci 2010;51:2984.
81. Thomas T, Ginsberg H. Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia. Curr Atheroscler Rep 2010;12:58-65.
82. Wierzbicki AS, Hardman T, Prince WT. Future challenges for microsomal transport protein inhibitors. Curr Vasc Pharmacol 2009;7:277-86.
83. Tomoda H, Omura S. Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Pharmacol Ther 2007;115:375-89. (Pubitemid 47362374)
84. Samuel W, Kutty RK, Nagineni S, et al. Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid. J Biol Chem 2001;276:28744-50.
85. Brown JM, Rudel LL. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 2010;21:192-7.
86. Zarbin MA, Montemagno C, Leary JF, et al. Nanomedicine in ophthalmology: the new frontier. Am J Ophthalmol 2010;150:144-62 -2.
87. Funatsu T, Suzuki K, Goto M, et al. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. Atherosclerosis 2001;157:107-15. (Pubitemid 32539359)
88. Elner VM. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc 2002;100:301-38. (Pubitemid 37039377)
89. SanGiovanni JP, Chew EY, Agron E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008;126:1274-9.
90. Chiu CJ, Klein R, Milton RC, et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? Br J Ophthalmol 2009;93:1241-6.
91. Chong EW, Robman LD, Simpson JA, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009;127:674-80.
92. Maminishkis A, Chen S, Jalickee S, et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 2006;47:3612-24. (Pubitemid 351639731)
93. Sonoda S, Spee C, Barron E, et al. A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc 2009;4:662-73.
94. Raabe M, Veniant MM, Sullivan MA, et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 1999;103:1287-98. (Pubitemid 29218299)
95. Bretillon L, Acar N, Seeliger MW, et al. ApoB100, LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci 2008;49:1307-14.
96. Fujihara M, Bartels ED, Nielsen LB, et al. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp Eye Res 2009;88:1115-23.
97. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
98. Cohen JC, Boerwinkle E, Mosley TH Jr, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-72.
99. Zareparsi S, Buraczynska M, Branham KE, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005;14:1449-55. (Pubitemid 40834203)
100. Khanifar AA, Koreishi AF, Izatt JA, et al. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008;115:1883-90.
101. Spraul CW, Grossniklaus HE. Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol 1997;115:267-73. (Pubitemid 27083801)
102. Bressler SB, Bressler NM, Sarks SH, et al. Age-related macular degeneration: nonneovascular early AMD, intermediate AMD, and geographic atrophy. In: Ryan SJ, ed. Retina: Mosby, 2006:1041-74.
103. Guyton JR, Klemp KR. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996;16:4-11. (Pubitemid 26026925)
104. Koh AS, Chia S. Update on clinical imaging of coronary plaque in acute coronary syndrome. Ann Acad Med Singapore 2010;39:203-9.
105. Garcia-Garcia HM, Gonzalo N, Regar E, et al. Virtual histology and optical coherence tomography: from research to a broad clinical application. Heart 2009;95:1362-74.
106. Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque: how far have we got? Eur Heart J 2009;30:2566-74.
107. Ruberg FL, Viereck J, Phinikaridou A, et al. Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS. J Lipid Res 2006;47:310-17. (Pubitemid 43276916)